文献速递临床试验与 GCP

测量执业护士主导的照护对多发性硬化症患者抑郁和焦虑水平的影响:一项随机对照试验的研究方案

Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-11-08

本研究为平行随机对照试验,旨在确定执业护士(NP)主导的照护对多发性硬化症(MS)患者抑郁和焦虑水平的影响。由普通私人执业神经科医生随访的MS患者将被随机分配至NP主导照护组或常规照护对照组。主要结局为3个月时医院焦虑抑郁量表(HADS)评分变化差异。

要点

  • 研究纳入由普通私人执业神经科医生随访的MS患者,随机分为NP主导照护组与常规照护对照组。
  • 主要结局为3个月时HADS测量的焦虑和抑郁评分变化差异。
  • 次要结局包括6个月HADS变化、3和6个月MSIF与EQ-5D评分、CAREQOL-MS、就诊和电话次数及满意度。

核心结论

  • 研究结果将有助于探索高级执业护士干预对社区环境中由普通神经科医生和家庭医生随访的MS患者的益处,为NP主导照护提供证据,并为MS管理提供替代医疗资源。

研究设计与样本

  • 平行随机对照试验。
  • 研究对象为由普通私人执业神经科医生随访的多发性硬化症患者。
  • 干预组接受NP主导照护,在基线访视时由NP评估并提供照护,并在3个月和6个月进行随访访视。
  • 对照组接受常规照护,由社区神经科医生或家庭医生提供,并由具有MS照护经验的注册护士提供标准协助。

关键数值与推荐

  • 主要结局:3个月时通过经验证的医院焦虑抑郁量表(HADS)问卷测量的患者焦虑和抑郁评分变化差异。
  • 次要结局:6个月时HADS变化差异;3和6个月时改良疲劳影响量表(MSIF)评分;3和6个月时EQ-5D评分;3和6个月时MS照护者健康相关生活质量测量(CAREQOL-MS);患者记录的向医疗专业人员就诊和电话次数;通过经验证的顾问满意度问卷测量的对NP主导照护与常规照护的满意度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Canada has one of the highest rates of multiple sclerosis (MS) in the world. Treatments and supports for people with MS (PwMS) have become increasingly complex, requiring individualized and adaptive care. Specialized NPs provide advanced skills to those with complex medical conditions, with potential to enhance the health, functioning, and quality of life for PwMS. This study aims to determine the effect of a Nurse Practitioner (NP) on depression and anxiety levels in PwMS. METHODS: We will perform a parallel randomized controlled trial. PwMS who are followed by general private-practice neurologists will be randomly assigned to the intervention group (NP-led care) or the 'usual care' control group (general neurologist or family physician and registered nurse support). In the intervention group, the NP will assess and provide care to the MS patient and their caregiver at a baseline visit, with 3-month and 6-month follow-up visits. PwMS in the control group will receive usual care provided by their community neurologists or family physicians with the standard assistance provided by registered nurses experienced in MS care. The primary outcome will be the difference in change in the patient's anxiety and depression scores as measured by the validated Hospital Anxiety and Depression Scale (HADS) questionnaire at 3 months. Secondary outcomes will include difference in change in HADS at 6 months; Modified Fatigue Impact Scale scores (MSIF) at 3 and 6 months; EQ-5D scores at 3 and 6 months; caregiver health-related quality of life in MS measures (CAREQOL-MS) at 3 and 6 months; number of visits and phone calls to healthcare professionals recorded by patient, and satisfaction with NP-led care vs usual care measured by the validated Consultant Satisfaction Questionnaire. DISCUSSION: Findings from this study will contribute to exploring benefits of advanced nursing practitioner interventions for PwMS followed by general neurologists and family physicians in a community setting. It will provide evidence of the benefits of NP-led care for PwMS and offer an alternative healthcare resource for management of MS. TRIAL REGISTRATION: ClinicalTrials.gov Pro00069595 . Retrospectively registered on June 26, 2020. Protocol version: January 2017, version 1.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Smyth P, Watson KE, Tsuyuki RT, et al. Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial. Trials. 2021. PMID: 34749784. doi:10.1186/s13063-021-05726-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。